Simplex Trading’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.5K Sell
473
-225
-32% -$10.1K ﹤0.01% 6682
2025
Q4
$22.1K Buy
+698
New +$21.8K ﹤0.01% 6380
2024
Q3
Sell
-1,200
Closed -$57.1K 9626
2024
Q2
$59K Buy
+1,200
New +$48.9K ﹤0.01% 5918
2023
Q1
Sell
-16,048
Closed -$355K 10172
2022
Q4
$382K Buy
16,048
+15,044
+1,498% +$436K ﹤0.01% 3469
2022
Q3
$35K Buy
1,004
+879
+703% +$37.3K ﹤0.01% 6903
2022
Q2
$4K Buy
+125
New +$4.43K ﹤0.01% 9040
2022
Q1
Sell
-72
Closed -$3.99K 11428
2021
Q4
$5K Sell
72
-668
-90% -$68.6K ﹤0.01% 9569
2021
Q3
$97K Hold
740
﹤0.01% 6657
2021
Q2
$98K Sell
740
-56
-7% -$6.51K ﹤0.01% 6758
2021
Q1
$98K Sell
796
-446
-36% -$67.7K ﹤0.01% 5781
2020
Q4
$175K Buy
1,242
+1,045
+530% +$116K ﹤0.01% 4794
2020
Q3
$14K Buy
+197
New +$12.3K ﹤0.01% 6625

Other funds holding TWST

Simplex Trading's TWST Position: Q1 2026 in Review

Simplex Trading reduced its Twist Bioscience (TWST) stake by 32% in Q1 2026, selling an estimated $10.1K and leaving 473 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6682.

Simplex Trading first reported a position in TWST in Q3 2020 and has held it in 12 quarters since. The position peaked at $382K in Q4 2022. 280 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Simplex Trading held 473 shares of Twist Bioscience worth $22.5K as of Q1 2026.
  • Simplex Trading sold 225 Twist Bioscience shares in Q1 2026, an estimated $10.1K.
  • Twist Bioscience made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6682 holding.
  • Simplex Trading first reported a position in Twist Bioscience in Q3 2020 and has held it in 12 quarters since.
  • Simplex Trading's Twist Bioscience position peaked at $382K in Q4 2022.
  • 280 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.